Arnesen E, Thelle D S, Førde O H, Mjøs O D
J Epidemiol Community Health. 1983 Jun;37(2):141-4. doi: 10.1136/jech.37.2.141.
As a side project to a study of coronary risk factors 4878 men and women aged 20-53 were interviewed about present and previous use of antihypertensive drugs. Serum lipid and glucose concentrations were compared in 124 present users, 73 previous users, and 124 controls matched for age, sex, and systolic and diastolic blood pressure. Users of betablockers, thiazides, and other antihypertensive drugs had higher total cholesterol, triglycerides, and glucose and lower HDL-cholesterol than the other groups, but only the difference in HDL-cholesterol was statistically significant. Smokers had statistically significant lower HDL-cholesterol than non-smokers in drug users, whereas there were only minor differences between them in previous and never users. This indicates an interaction between smoking and current antihypertensive medication. The unfavourable serum lipid pattern may, if caused by drug use, explain the lack of influence that antihypertensive treatment has had on the incidence of coronary heart disease in intervention studies.
作为一项冠心病危险因素研究的附带项目,对4878名年龄在20至53岁之间的男性和女性进行了访谈,询问他们目前和过去使用抗高血压药物的情况。对124名目前使用者、73名过去使用者以及124名在年龄、性别、收缩压和舒张压方面相匹配的对照者的血脂和血糖浓度进行了比较。使用β受体阻滞剂、噻嗪类药物和其他抗高血压药物的人群,其总胆固醇、甘油三酯和血糖水平高于其他组,但只有高密度脂蛋白胆固醇的差异具有统计学意义。在药物使用者中,吸烟者的高密度脂蛋白胆固醇水平在统计学上显著低于非吸烟者,而在过去使用者和从未使用者中,两者之间只有微小差异。这表明吸烟与当前的抗高血压药物之间存在相互作用。如果血脂模式不利是由药物使用引起的,那么这可能解释了在干预研究中抗高血压治疗对冠心病发病率缺乏影响的原因。